This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Merrimack Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ross Bane Fulton: Innovator in Cancer and Autoimmune Disease Treatment
Introduction
Ross Bane Fulton is a notable inventor based in Southborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating cancer and autoimmune diseases.
Latest Patents
Ross Bane Fulton holds a patent for "Anti-TNFR2 antibodies and uses thereof." This patent discloses anti-TNFR2 antibodies, therapeutic compositions that include these antibodies, and methods for utilizing them in the treatment of various medical conditions, including cancer and autoimmune diseases.
Career Highlights
Fulton is currently associated with Merrimack Pharmaceuticals, Inc., where he applies his expertise in antibody development. His work at Merrimack has positioned him as a key player in the advancement of therapeutic options for patients suffering from challenging health conditions.
Collaborations
He has collaborated with notable colleagues, including Yu Zhou and James David Marks, to further enhance the research and development of innovative treatments.
Conclusion
Ross Bane Fulton exemplifies the spirit of innovation in the biotechnology sector, contributing valuable advancements in the treatment of cancer and autoimmune diseases through his patented work.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile